Published in PLoS One on November 19, 2013
Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc (2000) 39.79
Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc (2007) 20.11
Gait speed and survival in older adults. JAMA (2011) 15.01
Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med (2002) 7.77
Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science (2005) 4.76
Competing risk regression models for epidemiologic data. Am J Epidemiol (2009) 4.75
Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ (2010) 4.64
A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med (1999) 4.61
Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA (1993) 4.01
Relationship of walking to mortality among US adults with diabetes. Arch Intern Med (2003) 3.95
Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc (2001) 3.74
Death certificate completion: how well are physicians trained and are cardiovascular causes overstated? Am J Med (2004) 3.66
Physical activity and coronary heart disease in women: is "no pain, no gain" passé? JAMA (2001) 3.65
Six minute walking distance in healthy elderly subjects. Eur Respir J (1999) 3.56
Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med (2012) 3.50
Accuracy of death certificate completion: the need for formalized physician training. JAMA (1996) 3.09
Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation (2003) 2.80
Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med (2008) 2.64
Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ (2009) 2.62
Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2006) 2.36
The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J (2009) 1.81
Physical activity and cause-specific mortality in the Whitehall study. Public Health (2000) 1.78
Vigorous exercise, fitness and incident hypertension, high cholesterol, and diabetes. Med Sci Sports Exerc (2008) 1.72
Physical activity and cardiovascular disease risk in middle-aged and older women. Am J Epidemiol (1999) 1.57
Reduction in incident stroke risk with vigorous physical activity: evidence from 7.7-year follow-up of the national runners' health study. Stroke (2009) 1.21
Physiologic, psychologic, and health predictors of 6-minute walk performance in older people. Arch Phys Med Rehabil (2002) 1.20
Intensity versus duration of walking, impact on mortality: the Copenhagen City Heart Study. Eur J Cardiovasc Prev Rehabil (2007) 1.16
Nonlinear relationships between weekly walking distance and adiposity in 27,596 women. Med Sci Sports Exerc (2005) 1.13
Walking behaviors reported in the American Time Use Survey 2003-2005. J Phys Act Health (2008) 1.06
Association of walking speed in late midlife with mortality: results from the Whitehall II cohort study. Age (Dordr) (2012) 1.04
Reduced diabetic, hypertensive, and cholesterol medication use with walking. Med Sci Sports Exerc (2008) 1.03
Six-minute walking test but not ejection fraction predicts mortality in elderly patients undergoing cardiac rehabilitation following coronary artery bypass grafting. Eur J Prev Cardiol (2011) 0.96
Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure. Can J Cardiol (2008) 0.95
Association between walking distance and percentiles of body mass index in older and younger men. Br J Sports Med (2008) 0.94
Prognostic value of the six-minute walk test in end-stage renal disease life expectancy: a prospective cohort study. Clinics (Sao Paulo) (2012) 0.91
The 6-minute walk test as a predictor of objectively measured aerobic fitness in healthy working-aged adults. Phys Sportsmed (2011) 0.85
Dose-response relationship of physical activity to premature and total all-cause and cardiovascular disease mortality in walkers. PLoS One (2013) 0.84
Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc (2007) 20.11
Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32
The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol (2005) 3.43
Cardiac arrest during long-distance running races. N Engl J Med (2012) 3.34
Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. Circulation (2010) 2.89
Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation (2013) 2.82
The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol (2007) 2.68
Effect of statins on skeletal muscle function. Circulation (2012) 2.54
Exercise intensity alters postexercise hypotension. J Hypertens (2004) 2.45
Phytosterols and vascular disease. Atherosclerosis (2005) 2.39
Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins. Arterioscler Thromb Vasc Biol (2005) 2.12
Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol (2010) 2.06
SLC30A8 nonsynonymous variant is associated with recovery following exercise and skeletal muscle size and strength. Diabetes (2013) 2.05
Variability in muscle size and strength gain after unilateral resistance training. Med Sci Sports Exerc (2005) 1.95
ACE ID genotype and the muscle strength and size response to unilateral resistance training. Med Sci Sports Exerc (2006) 1.86
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation (2004) 1.82
Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol (2009) 1.78
Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes. Exerc Sport Sci Rev (2012) 1.76
Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol (2009) 1.68
The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis (2010) 1.65
Serum creatine kinase levels and renal function measures in exertional muscle damage. Med Sci Sports Exerc (2006) 1.63
Lipid-lowering efficacy of red yeast rice in a population intolerant to statins. Am J Cardiol (2010) 1.59
ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol (1985) (2005) 1.57
Postexercise hypotension differs between white and black women. Am Heart J (2003) 1.51
Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports. Chest (2008) 1.51
Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components. J Appl Physiol (1985) (2006) 1.45
Lipids, lipoproteins, and exercise. J Cardiopulm Rehabil (2002) 1.41
Breast cancer mortality vs. exercise and breast size in runners and walkers. PLoS One (2013) 1.40
Physiogenomic association of statin-related myalgia to serotonin receptors. Muscle Nerve (2007) 1.35
The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J Steroid Biochem Mol Biol (2010) 1.34
Screening for sudden cardiac death in the young: report from a national heart, lung, and blood institute working group. Circulation (2011) 1.30
The additive blood pressure lowering effects of exercise intensity on post-exercise hypotension. Am Heart J (2010) 1.24
The genetics of statin-induced myopathy. Atherosclerosis (2009) 1.22
Molecular responses of human muscle to eccentric exercise. J Appl Physiol (1985) (2003) 1.17
Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4. J Cell Biochem (2005) 1.17
Effect of statins on creatine kinase levels before and after a marathon run. Am J Cardiol (2011) 1.17
Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol (2005) 1.16
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Arterioscler Thromb Vasc Biol (2003) 1.14
Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation (2009) 1.12
Rapid upregulation and clearance of distinct circulating microRNAs after prolonged aerobic exercise. J Appl Physiol (1985) (2014) 1.12
Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis. Pharmacogenomics (2005) 1.10
Decreasing LDL cholesterol and medication cost with every-other-day statin therapy. Prev Cardiol (2005) 1.07
Dose-dependent effects of training and detraining on weight in 6406 runners during 7.4 years. Obesity (Silver Spring) (2006) 1.06
The effects of statins on skeletal muscle strength and exercise performance. Curr Opin Lipidol (2010) 1.05
Mechanisms of statin-induced myalgia assessed by physiogenomic associations. Atherosclerosis (2011) 1.05
Exercise prescription and primary prevention of cardiovascular disease. Circulation (2010) 1.04
RAAS polymorphisms alter the acute blood pressure response to aerobic exercise among men with hypertension. Eur J Appl Physiol (2006) 1.04
Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance. Ann Pharmacother (2008) 1.04
Walking versus running for hypertension, cholesterol, and diabetes mellitus risk reduction. Arterioscler Thromb Vasc Biol (2013) 1.04
The influence of short and long duration on the blood pressure response to an acute bout of dynamic exercise. Am Heart J (2006) 1.04
Inflammatory gene changes associated with the repeated-bout effect. Am J Physiol Regul Integr Comp Physiol (2008) 1.04
Alterations in osteopontin modify muscle size in females in both humans and mice. Med Sci Sports Exerc (2013) 1.03
Statins as a possible cause of inflammatory and necrotizing myopathies. Atherosclerosis (2011) 1.03
The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. Atherosclerosis (2008) 1.01
Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women. Am J Physiol Heart Circ Physiol (2011) 1.01
Urban ethnic minority women's attendance at health clinic vs. church based exercise programs. J Cross Cult Gerontol (2006) 1.00
Statin myopathy: incidence, risk factors, and pathophysiology. Curr Atheroscler Rep (2007) 0.99
PPARalpha L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males. BMC Med Genet (2007) 0.99
Exercise-related spontaneous coronary artery dissection: case report and literature review. Med Sci Sports Exerc (2007) 0.99
Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. Cytokine (2008) 0.98
Forty-eight hours of unloading and 24 h of reloading lead to changes in global gene expression patterns related to ubiquitination and oxidative stress in humans. J Appl Physiol (1985) (2010) 0.98
Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review. Atherosclerosis (2007) 0.97
A systematic review of LDL apheresis in the treatment of cardiovascular disease. Atherosclerosis (2006) 0.96
Protecting athletes from sudden cardiac death. JAMA (2006) 0.95
INSIG2 gene polymorphism is associated with increased subcutaneous fat in women and poor response to resistance training in men. BMC Med Genet (2008) 0.94
Tendon rupture associated with simvastatin/ezetimibe therapy. Am J Cardiol (2007) 0.93
AKT1 polymorphisms are associated with risk for metabolic syndrome. Hum Genet (2011) 0.92
Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity. Med Sci Sports Exerc (2009) 0.91
Updating ACSM's Recommendations for Exercise Preparticipation Health Screening. Med Sci Sports Exerc (2015) 0.91
Relation of vitamin D level to maximal oxygen uptake in adults. Am J Cardiol (2011) 0.91
Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins. Am J Cardiol (2008) 0.91
Effect of female sex on cardiac arrhythmias. Cardiol Rev (2012) 0.91
Dietary calcium intake and renin angiotensin system polymorphisms alter the blood pressure response to aerobic exercise: a randomized control design. Nutr Metab (Lond) (2007) 0.91
Statin and exercise prescription. Lancet (2013) 0.90
Influence of chronic exercise on carotid atherosclerosis in marathon runners. BMJ Open (2014) 0.90
Differences in fat and muscle mass associated with a functional human polymorphism in a post-transcriptional BMP2 gene regulatory element. J Cell Biochem (2009) 0.89
25(OH) vitamin D is associated with greater muscle strength in healthy men and women. Med Sci Sports Exerc (2013) 0.89
CCL2 and CCR2 variants are associated with skeletal muscle strength and change in strength with resistance training. J Appl Physiol (1985) (2010) 0.88
Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training. Atherosclerosis (2005) 0.88
The muscle strength and size response to upper arm, unilateral resistance training among adults who are overweight and obese. J Strength Cond Res (2007) 0.87
Subcutaneous fat alterations resulting from an upper-body resistance training program. Med Sci Sports Exerc (2007) 0.87
Corneal arcus as coronary artery disease risk factor. Atherosclerosis (2006) 0.87
CNTF 1357 G -> A polymorphism and the muscle strength response to resistance training. J Appl Physiol (1985) (2009) 0.87
Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging (2013) 0.87
Managing statin myopathy. Endocrinol Metab Clin North Am (2009) 0.87
Transcriptional deficits in oxidative phosphorylation with statin myopathy. Muscle Nerve (2011) 0.87
A meta-analysis of aortic root size in elite athletes. Circulation (2013) 0.87
Do the frequencies of adverse events increase, decrease, or stay the same with long-term use of statins? Curr Atheroscler Rep (2013) 0.86
Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance. Atherosclerosis (2013) 0.86
Carotid and peripheral atherosclerosis in male marathon runners. Med Sci Sports Exerc (2011) 0.86
The metabolic syndrome and the immediate antihypertensive effects of aerobic exercise: a randomized control design. BMC Cardiovasc Disord (2008) 0.85
Effect of marathon run and air travel on pre- and post-run soluble d-dimer, microparticle procoagulant activity, and p-selectin levels. Am J Cardiol (2012) 0.85
Resistin polymorphisms are associated with muscle, bone, and fat phenotypes in white men and women. Obesity (Silver Spring) (2007) 0.85
Telomere length and cardiorespiratory fitness in marathon runners. J Investig Med (2013) 0.85